Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

618
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
618
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

2.0K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
2.0K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

6.5K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.5K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

355
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
355

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Snapshot of Four-Chamber Adipocyte Distribution in the Human Heart.

Academic forensic pathology·2026
Same author

Community-Academic Workshop on Translating Research Findings into Policy Briefs for Broader Dissemination.

Ethnicity & disease·2026
Same author

DMPK 3' untranslated repeat expansions in unexplained sudden cardiac death in the young.

European heart journal·2026
Same author

Fatigue Is a Key Contributor to Quality of Life in Heart Valve Disease and After Valve Replacement/Repair: A Qualitative Study.

Heart, lung & circulation·2026
Same author

Effects of dual front-of-pack nutrition and sustainability labelling on consumer understanding, purchase intentions, food choices and willingness to pay: A systematic literature review.

Appetite·2026
Same author

The semantic differential questionnaire format warrants consideration for use in healthcare settings.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026

Related Experiment Video

Updated: Jan 14, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

19.8K

Riboflavin supplements for blood pressure lowering in adults.

Kathryn E Bradbury1, Sean Coffey2, Nikki Earle3

  • 1School of Population Health, University of Auckland, Auckland, New Zealand.

The Cochrane Database of Systematic Reviews
|October 22, 2025
PubMed
Summary

The evidence is very uncertain regarding riboflavin supplements

More Related Videos

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

14.0K
Inactivation of Pathogens via Visible-Light Photolysis of Riboflavin-5′-Phosphate
08:25

Inactivation of Pathogens via Visible-Light Photolysis of Riboflavin-5′-Phosphate

Published on: April 6, 2022

2.2K

Related Experiment Videos

Last Updated: Jan 14, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

19.8K
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

14.0K
Inactivation of Pathogens via Visible-Light Photolysis of Riboflavin-5′-Phosphate
08:25

Inactivation of Pathogens via Visible-Light Photolysis of Riboflavin-5′-Phosphate

Published on: April 6, 2022

2.2K

Area of Science:

  • Cardiovascular Health
  • Nutritional Science
  • Genetics

Background:

  • Elevated blood pressure increases cardiovascular disease risk.
  • Riboflavin (vitamin B2) is being investigated for its potential to lower blood pressure, especially in individuals with the MTHFR C677T polymorphism.
  • This review assesses the efficacy and safety of riboflavin supplementation for blood pressure management.

Purpose of the Study:

  • To evaluate the benefits and harms of riboflavin supplements compared to placebo for reducing systolic and diastolic blood pressure.
  • To assess the impact of riboflavin on antihypertensive medication use and adverse events.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted.
  • Searches included major databases (Cochrane Hypertension, CENTRAL, MEDLINE, Embase, Web of Science) up to October 2024.
  • Four RCTs with 374 participants were included; risk of bias was assessed using Cochrane RoB 2 tool. Subgroup analyses included MTHFR C677T genotype.

Main Results:

  • Evidence on riboflavin's effect on systolic blood pressure (MD -1.94 mmHg) and diastolic blood pressure (MD -3.03 mmHg) is very uncertain due to low-certainty evidence from few studies with high risk of bias.
  • No significant reduction in blood pressure was definitively established.
  • One RCT indicated low-certainty evidence suggesting little to no difference in adverse events between riboflavin and control groups.

Conclusions:

  • The current evidence regarding the effect of oral riboflavin supplements on blood pressure is very uncertain.
  • The included studies had a high risk of bias, limiting definitive conclusions.
  • Larger, high-quality randomized controlled trials are necessary to establish the efficacy of riboflavin for blood pressure lowering.